Cullen/Frost Bankers’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$49.6K Buy
186
+10
+6% +$2.71K ﹤0.01% 799
2025
Q4
$44.3K Buy
176
+14
+9% +$3.72K ﹤0.01% 823
2025
Q3
$46.4K Buy
162
+82
+103% +$22K ﹤0.01% 765
2025
Q2
$21.1K Buy
80
+9
+13% +$2.19K ﹤0.01% 913
2025
Q1
$16.6K Sell
71
-1
-1% -$243 ﹤0.01% 874
2024
Q4
$16.6K Sell
72
-31
-30% -$7.11K ﹤0.01% 806
2024
Q3
$23.1K Sell
103
-261
-72% -$57.4K ﹤0.01% 798
2024
Q2
$74K Sell
364
-650
-64% -$132K ﹤0.01% 627
2024
Q1
$222K Hold
1,014
﹤0.01% 462
2023
Q4
$230K Sell
1,014
-126
-11% -$26.5K ﹤0.01% 462
2023
Q3
$229K Sell
1,140
-266
-19% -$56.1K ﹤0.01% 481
2023
Q2
$292K Sell
1,406
-84
-6% -$16.3K 0.01% 456
2023
Q1
$294K Buy
1,490
+4
+0.3% +$823 0.01% 454
2022
Q4
$301K Buy
1,486
+37
+3% +$7.23K 0.01% 451
2022
Q3
$255K Sell
1,449
-19
-1% -$3.89K 0.01% 465
2022
Q2
$296K Sell
1,468
-157
-10% -$33.5K 0.01% 454
2022
Q1
$368K Sell
1,625
-35
-2% -$8.23K 0.01% 443
2021
Q4
$448K Sell
1,660
-510
-24% -$126K 0.01% 421
2021
Q3
$525K Sell
2,170
-479
-18% -$121K 0.01% 387
2021
Q2
$628K Sell
2,649
-346
-12% -$78.8K 0.01% 369
2021
Q1
$656K Sell
2,995
-1,293
-30% -$259K 0.01% 353
2020
Q4
$749K Sell
4,288
-260
-6% -$44.9K 0.02% 319
2020
Q3
$735K Sell
4,548
-514
-10% -$81.5K 0.02% 301
2020
Q2
$722K Sell
5,062
-1,490
-23% -$206K 0.02% 305
2020
Q1
$711K Sell
6,552
-1,754
-21% -$253K 0.02% 273
2019
Q4
$1.21M Sell
8,306
-1,603
-16% -$231K 0.03% 257
2019
Q3
$1.43M Sell
9,909
-96
-1% -$14K 0.04% 241
2019
Q2
$1.49M Sell
10,005
-2,181
-18% -$304K 0.05% 222
2019
Q1
$1.6M Sell
12,186
-2,844
-19% -$350K 0.05% 210
2018
Q4
$1.63M Sell
15,030
-843
-5% -$113K 0.06% 202
2018
Q3
$2.37M Sell
15,873
-9,293
-37% -$1.41M 0.07% 188
2018
Q2
$3.88M Sell
25,166
-398
-2% -$60.1K 0.12% 159
2018
Q1
$3.55M Buy
25,564
+2,130
+9% +$313K 0.1% 169
2017
Q4
$3.21M Sell
23,434
-799
-3% -$106K 0.1% 170
2017
Q3
$3.14M Sell
24,233
-11
-0% -$1.47K 0.1% 169
2017
Q2
$3.21M Buy
24,244
+19
+0.1% +$2.33K 0.11% 171
2017
Q1
$2.99M Sell
24,225
-26,158
-52% -$3.1M 0.1% 165
2016
Q4
$5.56M Sell
50,383
-272
-0.5% -$30.2K 0.19% 133
2016
Q3
$5.98M Sell
50,655
-1,962
-4% -$231K 0.21% 125
2016
Q2
$5.89M Sell
52,617
-1,624
-3% -$175K 0.22% 122
2016
Q1
$5.46M Sell
54,241
-568
-1% -$54.5K 0.2% 122
2015
Q4
$5.82M Sell
54,809
-1
-0% -$103 0.22% 123
2015
Q3
$5.11M Sell
54,810
-872
-2% -$90.2K 0.2% 126
2015
Q2
$5.8M Sell
55,682
-31
-0.1% -$3.23K 0.22% 124
2015
Q1
$6.04M Buy
55,713
+54
+0.1% +$5.55K 0.23% 123
2014
Q4
$5.16M Sell
55,659
-559
-1% -$49.4K 0.2% 133
2014
Q3
$4.91M Sell
56,218
-647
-1% -$58.5K 0.2% 129
2014
Q2
$5M Buy
56,865
+16,417
+41% +$1.42M 0.2% 132
2014
Q1
$3.41M Buy
40,448
+437
+1% +$34.8K 0.15% 158
2013
Q4
$3.14M Buy
40,011
+17,292
+76% +$1.47M 0.14% 159
2013
Q3
$1.94M Buy
22,719
+1,471
+7% +$124K 0.09% 187
2013
Q2
$1.83M Buy
+21,248
New +$1.76M 0.1% 185

Other funds holding LH

Cullen/Frost Bankers's LH Position: Q1 2026 in Review

Cullen/Frost Bankers increased its Labcorp (LH) stake by 5.7% in Q1 2026, buying an estimated $2.71K and bringing the position to 186 shares worth $49.6K. The position accounts for ﹤0.01% of the portfolio, ranked #799.

Cullen/Frost Bankers first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.04M in Q1 2015. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Cullen/Frost Bankers held 186 shares of Labcorp worth $49.6K as of Q1 2026.
  • Cullen/Frost Bankers bought 10 Labcorp shares in Q1 2026, an estimated $2.71K.
  • Labcorp made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q1 2026, its #799 holding.
  • Cullen/Frost Bankers first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Cullen/Frost Bankers's Labcorp position peaked at $6.04M in Q1 2015.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Cullen/Frost Bankers's 13F filing for Q1 2026, filed 5 May 2026.